SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go? -- Ignore unavailable to you. Want to Upgrade?


To: BigKNY3 who wrote (7547)4/29/1999 12:37:00 AM
From: BigKNY3  Respond to of 9523
 
Big openings for new drugs

04/27/1999
USA Today
FINAL
Page 01B

Viagra 's first-year sales were the highest for recent new prescription drugs. Recent first-year U.S. sales over $450 million:

Drug (company, debut, treats) Sales (millions)

Viagra (Pfizer, 4/98, impotence) $635

Neupogen (Amgen, 4/97, infection)$591

Lipitor (Parke-Davis, 1/97, high cholesterol)$583

Taxol semi-synthetic (Bristol-Myers Squibb, 3/96, cancer)$481

Zyprexa (Eli Lilly, 10/96, depression)$458